Serum vascular endothelial growth factor in breast cancer

被引:0
|
作者
Byrne, G. J.
McDowell, G.
Agarawal, R.
Sinha, G.
Kumar, S.
Bundred, N. J.
机构
[1] S Manchester Univ Hosp Trust, Wythenshawe Hosp, Dept Surg, Manchester, Lancs, England
[2] Manchester Royal Infirm, Dept Clin Biochem, Manchester M13 9WL, Lancs, England
[3] Univ Manchester, Div Regenerat Med, Manchester, Lancs, England
关键词
VEGF; breast cancer; diagnosis; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Many studies have reported elevated serum concentrations of vascular endothelial growth factor (VEGF) in patients with cancer and claimed that the measurement of circulating VEGF is a surrogate marker of angiogenesis and/or metastasis. To determine the value of VEGF measurement in the diagnosis and prognosis of breast cancer, we measured levels in women with and without breast cancer. Platelet-depleted plasma VEGF levels were measured in premenopausal women at four-day intervals across the menstrual cycle, postmenopausal women and postmenopausal women who had undergone hysterectomy. Platelet-depleted plasma VEGF was also measured in pre- and postmenopausal women with early breast cancer (EBC) and levels compared with intratumoral levels, clinicopathological prognostic parameters and microvessel density. Levels of VEGF were determined using ELISA and immuno-histochemistry. Microvessel density was determined by immunohistochemical CD34 staining. Plasma VEGF in premenopausal women remained stable across the menstrual cycle except for a peak between days 8 and 12. VEGF levels in postmenopausal women were higher than in premenopausal women unless postmenopausal women had undergone hysterectomy. Amongst premenopausal women, levels of VEGF were high in 22 EBC patients when compared to normal premenopausal controls. No correlation was found between plasma and intratumoral VEGF, clinicopathological prognostic parameters or tumour microvessel density. The origin of circulating VEGF differs between pre- and postmenopausal women. Its measurement is unlikely to provide clinically useful diagnostic and prognostic information in women with early and advanced breast cancer.
引用
收藏
页码:3481 / 3487
页数:7
相关论文
共 50 条
  • [1] Serum vascular endothelial growth factor in breast cancer
    Heer, K
    Kumar, H
    Drew, PJ
    Fox, JN
    Carleton, PJ
    Monson, JRT
    Kerin, MJ
    [J]. BRITISH JOURNAL OF SURGERY, 1998, 85 (05) : 687 - 687
  • [2] Vascular Endothelial Growth Factor in the Serum of Breast Cancer Patients
    T. T. Berezov
    L. K. Ovchinnikova
    O. M. Kuznetsova
    Z. K. Karabekova
    I. K. Vorotnikov
    A. A. Tuleuova
    A. I. Katunina
    E. K. Dvorova
    [J]. Bulletin of Experimental Biology and Medicine, 2009, 148 : 419 - 424
  • [3] Vascular Endothelial Growth Factor in the Serum of Breast Cancer Patients
    Berezov, T. T.
    Ovchinnikova, L. K.
    Kuznetsova, O. M.
    Karabekova, Z. K.
    Vorotnikov, I. K.
    Tuleuova, A. A.
    Katunina, A. I.
    Dvorova, E. K.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2009, 148 (03) : 419 - 424
  • [4] Measurement of serum vascular endothelial growth factor in breast cancer patients
    Ferrero, S
    Nicoletti, A
    Ragni, N
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (05) : 310 - 311
  • [5] VASCULAR ENDOTHELIAL GROWTH FACTOR C SERUM LEVELS IN PATIENTS WITH BREAST CANCER
    Gisterek, I.
    Matkowski, R.
    Sedlaczek, P.
    Szewczyk, K.
    Staszek, U.
    Biecek, P.
    Lacko, A.
    Bebenek, M.
    Pudelko, M.
    Kornafel, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S207 - S207
  • [6] Measurement of serum vascular endothelial growth factor in breast cancer patients - Reply
    Sancak, B
    [J]. INTERNAL MEDICINE JOURNAL, 2005, 35 (05) : 311 - 311
  • [7] EVALUATION OF SERUM CONCENTRATIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN BREAST CANCER PATIENTS
    Hodorowicz-Zaniewska, Diana
    Kibil, Wojciech
    Malek, Agnieszka
    Szpor, Joanna
    Kulig, Jan
    Sztefko, Krystyna
    [J]. POLISH JOURNAL OF PATHOLOGY, 2012, 63 (04) : 255 - 260
  • [8] Vascular endothelial growth factor and breast cancer risk
    Reeves, Katherine W.
    Ness, Roberta B.
    Stone, Roslyn A.
    Weissfeld, Joel L.
    Vogel, Victor G.
    Powers, Robert W.
    Modugno, Francesmary
    Cauley, Jane A.
    [J]. CANCER CAUSES & CONTROL, 2009, 20 (03) : 375 - 386
  • [9] Vascular endothelial growth factor and breast cancer risk
    Katherine W. Reeves
    Roberta B. Ness
    Roslyn A. Stone
    Joel L. Weissfeld
    Victor G. Vogel
    Robert W. Powers
    Francesmary Modugno
    Jane A. Cauley
    [J]. Cancer Causes & Control, 2009, 20 : 375 - 386
  • [10] Serum vascular endothelial growth factor: a prognostic factor in cervical cancer
    Zusterzeel, Petra L. M.
    Span, Paul N.
    Dijksterhuis, Marja G. K.
    Thomas, Chris M. G.
    Sweep, Fred C. G. J.
    Massuger, Leon F. A. G.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (02) : 283 - 290